We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme into the Clinic

News   Apr 27, 2010

 
Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme into the Clinic
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News

Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn’t).

READ MORE

Promising Molecules for Stabilizing Abnormal Proteins That Cause AL Amyloidosis

News

Scientists at Scripps Research have identified a group of small molecules that prevent structural changes to proteins that are at the root of AL amyloidosis, a progressive and often fatal disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE